Born in Harare, Mike studied at the University of Zimbabwe. In 1977, he attended the IPSF Conference in Mexico and this stimulated his interest in global pharmacy. He worked in hospital and community pharmacy and was chief executive of Zimbabwe’s largest group of pharmacies before moving to the USA in 2001. He is Assistant Executive Director, Professional Affairs, and Director, International Services at the Accreditation Council for Pharmacy Education.Mike has published extensively, mainly in the areas of continuing professional development (CPD) and quality of pharmacy education. Mike established the International Forum for Quality Assurance of Pharmacy Educationand authored FIP’s Global Framework for Quality Assurance of Pharmacy Education(2008 and 2014). He is Lead for Quality Assurancein FIP’s Education Development Team. He also served as Co-Lead for Continuing Education/Continuing Professional Development.
Mikeserved as president of the Pharmaceutical Society of Zimbabwe and the National Pharmaceutical Council. For 30 years he has been active in FIP, serving on itsBoard of Directors, Board of Pharmaceutical Practice, Foundation for Education and Research, and Executive Committees of the Community and Academic Sections. He has travelled to over 70 countries, been a speaker at numerous nationaland international conferences, and served as a consultant on issues related to quality of pharmacy education, including for the WHO.
Dr Catriona Bradley
Dr Catriona Bradley was appointed as the Executive Director of the newly established Irish Institute of Pharmacy (IIOP) in March 2014. The IIOP is based in the Royal College of Surgeons in Ireland, and was established by the pharmacy regulator to establish and develop an innovative new CPD system for Irish pharmacy. A pharmacist by profession, Catriona graduated from Trinity College Dublin in 1998, and obtained her PhD in 2009. She worked for Boots for 14 years, and held senior leadership positions across the areas of pharmacy, business, education, research, human resource management and strategy development. She is also an adjunct associate professor in the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, where she contributes to the pharmacy practice programme. She has completed diplomas in Quality Improvement, Legal Studies and Coaching, and is a qualified executive and personal coach. She lives in Dublin with her husband and two children. She is passionate about supporting and enabling people and teams to realise their full potential and is looking forward to meeting the pharmacy leaders of the future at the IPSF world congress in Zimbabwe.
Professor Ralph J. Altiere
Ralph J. Altiere is Professor and Dean of the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA that is ranked 4th in research funding, top 20 percent of all US pharmacy schools with international education programs including the international PharmD (ITPD) program. His career in education and research spans nearly 40 years includingthe pharmaceutical industry and 35 years at the Universities of Kentucky and Colorado.
At Colorado, heled conversion from the BS in pharmacy to the PharmDprogram and had administrative oversight of aninnovative online post-BS PharmD program. He held several positions in AACP and is a co-author recipient of local and national innovations in teaching awards and the University of Colorado Anschutz Medical Campus Diversity Awards in 2004 and 2007. Professor Altiere holds leadership roles in the International Pharmaceutical Federation (FIP):President of the FIPAcademic Pharmacy Section and member of the FIPEducationExecutive Committee, FIP Board of Pharmacy Practice, FIP Congress Programme Committee and FIP Academic Institutional Membership Advisory Group. As part of his FIP work, he has conducted outreach efforts to the International Pharmaceutical Student Federation and pharmacy organizations worldwide including Asia, Africa and Latin America.
Dr Admire Dube
Dr. Admire Dube is a Senior Lecturer in Pharmaceutics at the School of Pharmacy, University of the Western Cape. He is a Pharmacist by training having graduated with a Bachelor of Pharmacy from the University of Zimbabwe. He also holds an Masters in Pharmaceutical Sciences (from the University of the Western Cape), a PhD in Pharmaceutical Sciences focusing on nanoparticle drug delivery systems, from Monash University, Australia, and Post-doctoral training in nanomedicine through the University at Buffalo, USA and the University of Zimbabwe. He previously held a position as Senior Researcher at the Council for Scientific and Industrial Research (CSIR) in Pretoria South Africa where he was involved in commercializing nanoparticle delivery systems for drugs used in malaria and tuberculosis. He currently leads a research laboratory which focuses on the development of nanomedicines for infectious diseases, in particular cellular targeted nanomedicines for drug delivery in tuberculosis and malaria treatment. He has published several articles on nanomedicine in high impact factor international journals, which have attracted over 260 citations. His h-index is 7. He has an interest in seeing Africa commercialize its first nanomedicine, and also in enhancing pharmaceutical production in Africa.
Dr Joey M. Chifamba
Dr Joey M. Chifamba is a Zimbabwean nano-pharmaceutics expert and applied industrial chemist both by qualification and experience. He has extensive dual, practical experience in both the industrial and academic sectors in pharmaceuticals, cosmeceuticals as well as industrial processes. Joey is a certified chartered, quality and manufacturing auditor with various other postgraduate qualifications in process technology, business management, supply chain management and quality assurance. Chifamba has worked as the Research and development manager and as the factory manager for Unilever South East Africa. He is a founding director forCornelder industries and the Siltek group of companies and ADRIC (Applied dermal research and innovation centre). Industrially, Dr Chifamba has vast geographical working experience including Zimbabwe, Zambia, Malawi, Namibia, SouthAfrica, Kenya, Middle East, India and the Caribbean islands. Academically, he has lectured at various universities inPharmaceutical nanotechnology, Pharmaceutics, Pharmaceutical industrial processes, and Pharmaceutical supply chain management as well as formulation technology.
Dr Chifamba’s main research interests are in nano-technological interventions in adverse dermatological conditions and neglected tropical diseases. Joey spends most of his leisure time outdoors, over-landingand alsoenjoys, art, theatre and playing various musical instruments.
Professor D. Tagwireyi
Dexter is an Associate Professor of Pharmacy (Toxicology and Pharmacology) and is a competent academic pharmacist-toxicologist, who has spent over 15 years in the academic environment of the University of Zimbabwe. He is a grantee of International Foundation for Science (IFS), a founding fellow of the Zimbabwe Young Academy of Sciences (ZIMYAS), a member of the Global Young Academy (GYA), TWAS-UNESCO Research Associate (Jul 2014 – Jun 2017), a fellow of the African Science Leadership Program (ASLP) and a Next Einstein Forum (NEF) Ambassador (2015/2016). He has expertise in Clinical and Applied Toxicology and working knowledge in the area of experimental neuropharmacology and toxicology. He has over 25 full publications peer refereed international publications in his area of expertise and numerous abstracts. He also has vast experience in setting up and running drug and poisons centres in an African setting. Prof Tagwireyi also has drug regulation experience in evaluating clinical trials (including trial site inspections), bioequivalence studies, veterinary clinical trials and drug dossiers, and currently sits in two expert committee of the Medicines Authority of Zimbabwe (MCAZ).
He also has experience in pharmacy profession regulation having served in the Education and Liaison Committee of the Pharmacists Council of Zimbabwe for almost a decade and being a current member of the Pharmacists Council of Zimbabwe (PCZ).Professor Tagwireyi is a seasoned and apt conference speaker.
Sherry L. Green
Sherry L. Green has 22 years of expertise in writing, analyzing, and training on prescription drug monitoring program (PMP) laws and policies. Ms. Green served as Associate Director of the President’s Commission on Model State Drug Laws and co-drafted the Commissions’ 44 model laws and policies. For 20 years, she served as CEO/Executive Director of the Commission’s non-profit successor, the National Alliance for Model State Drug Laws (NAMSDL). At NAMSDL, Ms. Green worked extensively on PMP issues with officials in the 50 U.S. states and Congress. Ms. Green continues her PMP work through her consulting company. She serves as the PMP expert for a U.S. health IT technology initiative, and serves on the operations subcommittee of a U.S. PMP working group. Ms. Green recently drafted a Model PMP Act for U.S. state controlled substances authorities, and she continues to educate professionals and officials in the U.S. and other countries on PMP laws and policies. In July 2016, Ms. Green will begin directing an action plan for NAMSDL that will help transform PMPs into better public health tools.
Ms. Green has a Juris Doctor from George Washington University in Washington D.C. and is a member of the Washington, D.C. Bar.
Nicolaouis Aspen’s Group Senior Executive responsible for Strategic Trade. Previously he was CEO of Aspen’s Export Division. Aspen is Africa’s largest and the world’s 6th largest generic Pharmaceutical Company by revenue ranking. He has been instrumental in introducing the first generic ARV’s on the African Continent developed by Aspen, which has gone on to save hundreds of thousands of lives in South Africa and on the African Continent. Nicolaou has over 24years’ experience in the South African and International Pharmaceutical Industry and is a previous winner of the SA Institute of Marketing Management (IMM) Health Care Marketer of the yearAward, the most prestigious of its kind at the time. He was recently inducted as one of the youngest Fellow of the Pharmaceutical Society of South Africa (PSSA), one of the highest honours bestowed by the PSSA.
He has previously andcontinues to serve on a number of Industry & Para-Government structures, some of which include:
- Is presently chairman of the Public Health Enhancement Fund (PHEF) – A joint collaboration between the Private Health Sector and the Ministry of Health.
- Appointed by the Minister of Public Enterprise as Chairman of the Board of SA Express Airways (2005-2009)
- Appointed by the Minister of Public Enterprises as a Non-Executive Directorof Transnet Ltd, SA’s second largest State owned Enterprise (2004-2010)
- Appointed by the Gauteng MEC for Economic Development as a Director of the Gauteng Growth and Development Agency (GGDA),
- Appointed by the Minister of Trade and Industry to serve on the Special Economic Zones (SEZ) Advisory Board.
- Appointed by the Minister of Trade and Industry to the BRICS Business Council (2013 to present)
- Appointed by the President of the Republic of South Africa, President JG Zuma to the Board of Brand SAin 2012 and was re-appointed for a further term in April 2016
- He serves as a Director on the North West University Business School Advisory Board
- Has served on the WORLD BANK/IFC technical Advisory Board on the strengthening of African Health Systems.
- Has served as Member of the IBSA (India Brazil South Africa) CEO’s Forum,
- Is presently Chairman of the South African local Pharmaceutical Producers (PHARMISA)
- Awarded the Order of the Lion of St Mark by the Greek Orthodox Pope and Patriarch, Theodoros II.
- Previously served as Vice-President of the International Pharmaceutical Students Federation (IPSF).
He has been a speaker at a number of conferences, including the Economist Roundtable,the World Economic Forum (WEF) and recently delivered a lecture on ARV developments at the Raigon Institute, a JV between Harvard Medical School and the Massachusetts General Hospital.
Countdown to the event
The 62nd World Congress is expected to be an exhilarating experience for all and inspire passion for the profession and federation